Young children with moderate‐to‐severe atopic dermatitis can be treated safely and effectively with either topical tacrolimus or mild corticosteroids

Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march

(2017) Tali Czarnowicki et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Usefulness of Rajka & Langeland Eczema Severity Score in Clinical Practice

(2016) A Gånemo et al.   ACTA DERMATO-VENEREOLOGICA

Early-onset pediatric atopic dermatitis is T H 2 but also T H 17 polarized in skin

(2016) Hitokazu Esaki et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants

(2015) Thomas Luger et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial

(2015) B. Sigurgeirsson et al.   PEDIATRICS

Food Allergy in Infants With Atopic Dermatitis: Limitations of Food-Specific IgE Measurements

(2015) J. M. Spergel et al.   PEDIATRICS

Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention

(2014) Eric L. Simpson et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Natural history of allergic sensitization in infants with early-onset atopic dermatitis: results from ORCA Study

(2014) Jocelyne Just et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis

(2013) S.G. Danby et al.   BRITISH JOURNAL OF DERMATOLOGY

Atopic dermatitis: a candidate for disease-modifying strategy

(2012) T. Bieber et al.   ALLERGY

Long-term efficacy and tolerability of tacrolimus 0.03% ointment in infants:* a two-year open-label study

(2011) Johanna M. Mandelin et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

One-year Treatment with 0.1% Tacrolimus Ointment versus a Corticosteroid Regimen in Adults with Moderate to Severe Atopic Dermatitis: A Randomized, Double-blind, Comparative Trial

(2010) J Mandelin et al.   ACTA DERMATO-VENEREOLOGICA

Long-term safety of tacrolimus ointment in atopic dermatitis

(2009) Anita Remitz et al.   Expert Opinion On Drug Safety

The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis

(2009) Sakari Reitamo et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis

(2009) Jens-Michael Jensen et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

A 4-year follow-up study of atopic dermatitis therapy with 0·1% tacrolimus ointment in children and adult patients

(2008) S. Reitamo et al.   BRITISH JOURNAL OF DERMATOLOGY

Sensitization to inhalant allergens between 4 and 8 years of age is a dynamic process: results from the BAMSE birth cohort

(2008) A. Asarnoj et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Recall antigen reactions in patients with atopic dermatitis treated with tacrolimus ointment for 1 year

(2008) Johanna Mandelin et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY